Division of Physical and Biological Sciences UCSC Home Biomedical Research Home

UCSC Biomedical Research Faculty Biomedical Research Clusters Laboratory Facilities Biocomputing Tools and Resources Research Funding Biomedical Research Training Programs Biomedical Research News

  Make a Gift

Division of Physical & Biological Sciences Baskin School of Engineering Center for Biomolecular Science & Engineering RNA CenterCalifornia Institute for Quantitative Biology UCSC Genome Browser Undergraduate Admissions Graduate Admissions PBSci Development Office

Physical & Biological Sciences
Nat Sci II Annex
UC Santa Cruz
1156 High Street
Santa Cruz, CA, 95064
Phone: 459-2931
Fax: 459-4161
Maps & Directions

 
CANCER
 
 

• Manel Camps (METX) Use of Random Mutagenesis for Studies of Evolution and for Therapy
• Phil Crews (Chem) Marine Natural Products as Anti-Cancer Compounds
• Camilla Forsberg (BME) How Stem Cell Fate Is Decided
• Lindsay Hinck (MCD) Loss of Growth Control and Cancer
• Ted Holman (Chem) Lipoxygenase Inhibitors as Potential Anti-Cancer Drugs
• Melissa Jurica (MCD) Structure and Functional Analysis of Spliceosomes
• Doug Kellogg (MCD) Mechanisms that Control Cell Division and Cell Growth
• Scott Lokey (Chem) A Small Molecule Approach for Studying Signaling Pathways Related to Cell Motility and Cancer
• Pradip Mascharak (Chem) Light-Activated Nitric Oxide Carriers: A New Path in Cancer Treatment
• Karen Ottemann (METX) Bacterial Pathogens Sense and Respond to Host Environments
• Seth Rubin (Chem) Molecular Mechanisms of Cell Cycle Regulation and Cancer
• Michael Stone (Chem) Assembly, Structure, and Regulation of the Telomerase Ribonucleoprotein
• Bill Sullivan (MCD) Cell Cycle, Cytoskeleton and Pathogenesis
• John Tamkun (MCD) Regulation of Chromatin Structure and Gene Expression
• Jin Zhang (Chem) The Application of Molecular and Nanomaterial Systems to the Detection and Treatment of Cancer
• Martha Zúñiga (MCD) Cellular and Molecular Regulation of Antigen Presentation in Health and Disease

Prof Manel CampsUse of Random Mutagenesis for Studies of Evolution and for Therapy

Manel Camps, Microbiology and Environmental Toxicology

The Camps laboratory uses molecular genetic and computational approaches to study  the biological consequences of random changes in genetic information  (mutations) that occur spontaneously  or as a result of environmental insults. They couple the generation of random mutant libraries with specific selections or screens  to study the functional impact of point mutations and to establish how genes evolve in response to selective pressure. This work is relevant for the identification of risk factors of disease, for understanding the origins of drug resistance, and for engineering biological activities. The Camps laboratory also use induction of random genetic alterations (mutagenesis) as an indicator of DNA damage for high-throughput analysis of chemical libraries. Through this approach, the Camps laboratory aims at exploiting the particular susceptibility of rapidly replicating cells to DNA damage for therapeutic purposes with the hopes of identifying candidates that complement or enhance existing anti-tumor therapies. [More]

Camps' Publications Manel Camps' Email

Prof Phil CrewsMarine Natural Products as Anti-Cancer Compounds

Phil Crews, Dept. of Chemistry and Biochemistry

The Crews laboratory investigates the chemical structure and biological activity of chemical compounds that are derived from marine organisms. Among its many research projects, the laboratory collaborates with scientists at other research institutions and pharmaceutical industries to explore the identification and development of naturally occuring compounds in the fight against cancer. [More]

Crews' Publications Phil Crews' E-Mail

Prof Camilla ForsgergHow Stem Cell Fate Is Decided

Camilla Forsberg, Dept. of Biomolecular Engineering

Camila Forsberg's research group focuses on stem cell fate decisions that give rise to variant blood cell types. Are such decisions made by the stem cell itself, by its descendant multipotent progenitors, or both? To answer such questions, Forsberg's group conducts molecular lineage tracing of HSC differentiation in vivo. In order to elucidate the mechanisms of fate decisions, they employ global analyses, such as genome-wide gene expression analysis and chromatin remodeling assays. The ultimate goal of this research is to facilitate our ability to direct specific fates and improve clinical applications of hematopoietic and non-hematopoietic stem cell therapy. [More]

Forsberg Publications Camilla Forsberg's Email

Prof Lindsay HInckLoss of Growth Control and Cancer

Lindsay Hinck, MCD Biology

One in eight women in the United States will develop breast cancer in her lifetime. Only about 15% of these cancers have been linked to specific gene mutations; therefore a major challenge in breast cancer research is to identify the causes of the disease. We have identified Slits as breast tumor suppressors that regulate several critical pathways controlling cell proliferation and migration. Current research focuses on developing therapeutic strategies to target these pathways. [More]

Hinck Publications Lindsay Hinck's Email

Prof HolmanLipoxygenase Inhibitors as Potential Anti-Cancer Drugs

Ted Holman, Dept. of Chemistry & Biochemistry

Lipoxygenases are enzymes implicated in a broad range of human cancers, as well as cardiac and inflammatory diseases. Ted Holman's laboratory examines the enzymatic mechanism and biological function of lipoxygenase in the hopes of developing novel inhibitors. In collaboration with UCSC Professor Phil Crews, his laboratory has identified potent lipoxygenase inhibitors and are currently characterizing their structure/function reactivity. The results of this work will shed light on their potential as anti-cancer agents. [More]

Holman's Publications Ted Holman's E-Mail

Prof Melissa JuricaStructure and Functional Analysis of Spliceosomes

Melissa Jurica, MCD Biology

The Jurica lab uses the tools of structural biology and biochemistry to investigate the cellular machinery responsible for editing the information contained in the RNA transcripts of nearly all of human genes.  This machinery, called the spliceosome, splices out intron sequences that interrupt gene transcripts and joins exon sequences to make messenger RNAs that correctly encode for proteins. The goal of Jurica's research is to understand how the spliceosome is assembled and how it catalyzes the splicing reaction, but this is ..... [More]
Melissa Jurica's Publications Melissa Jurica's E-Mail

Prof KelloggMechanisms that Control Cell Division and Cell Growth

Doug Kellogg, Dept. of MCD Biology

Cells show extraordinary diversity in size and shape.  The mechanisms by which cells control their growth and size are poorly understood and represent a fundamental unsolved problem in cell biology.  The goal of the Kellogg laboratory's work is to elucidate these mechanisms. Their approach is to use biochemistry, genetics, and mathematical modeling to understand signaling networks that are required for control of cell size and cell growth. [More]
Kellogg's Publications Doug Kellogg's E-Mail

Prof Scott LokeyA Small Molecule Approach for Studying Signaling Pathways Related to Cell Motility and Cancer

Scott Lokey, Chemistry and Biochemistry

The laboratory of Scott Lokey uses a small molecule approach, called chemical genetics, to study signaling pathways related to cell cycle checkpoints and the actin cytoskeleton. In one study, Lokey and his co-workers are developing screens of natural compounds that can be used to examine how cells detect their own DNA damage. Studies such as these might lead to development of a new class of chemotherapeutic agents. [More]

Lokey Publications Lokey's E-Mail

xxxLight-Activated Nitric Oxide Carriers: A New Path in Cancer Treatment

Pradip Mascharak, Chemistry and Biochemistry

Dr. Pradip Mascharak’s bioinorganic chemistry laboratory conducts basic and applied research regarding metal-based, nitric oxide (NO) carriers that release NO when activated by light.  In cancer cells, NO induces apoptosis (programmed cell death), which is the primary cellular mechanism of tumor clearing in chemotherapeutic treatments.  Unlike conventional chemotherapy where the drug is distributed systemically, Mascharak’s synthetic “NO donors” allow unique control over where, when, and how much NO is released. This “photodynamic” approach has intriguing implications for the development of drugs in treating skin and other cancers. [More]

Mascharak Publications Pradip Mascharak's Email

Prof Karen OttemannHow Bacterial Pathogens Sense and Respond to Host Environments

Karen Ottemann, Dept. of Microbiology and Environmental Toxicology

Professor Karen Ottemann's laboratory investigates how bacteria translate chemical and physical cues in their host environment into adaptive responses. Mistakes in sensation and subsequent gene expression by bacteria may result in their elimination by the host immune response or peristaltic flow. Elucidation of such processes will hopefully lead to identification of anti-bacterial drug targets. Ottemann is particularly interested in the role of chemoreceptors and chemotaxis associated with the bacterium Helicobacter pylori. This pathogen infects some 3 billion humans and can lead to serious disease, including ulcers and cancer. Ottemann and her colleagues have discovered two of the first chemoreceptors known to aid in the process of bacterial colonization. [More]

Ottemann Publications Karen Ottemann's Email

Prof RubinMolecular Mechanisms of Cell Cycle Regulation and Cancer

Seth Rubin, Chemistry and Biochemistry

The Rubin laboratory uses a variety of structural and biochemical techniques to investigate the molecular mechanisms that control the eukaryotic cell cycle. The aim is to elucidate detailed molecular pictures of protein-protein interactions and how these interactions are regulated by structural and chemical modifications. Improper regulation of these protein interaction networks is commonly associated with aberrant cell proliferation and cancer. [More]

Rubin Publications Seth Rubin's E-Mail


Prof Michael StoneAssembly, Structure, and Regulation of the Telomerase Ribonucleoprotein

Michael Stone, Dept. of Chemistry and Biochemistry

The Stone Research Group combines the use of biochemical and structural methods with newly emerging single-molecule techniques to probe the dynamics of protein-nucleic acid interactions and the molecular mechanisms of biological motors.  Our current area of focus is the structure and function of the telomerase ribonucleoprotein, an RNA-dependent DNA polymerase that maintains genomic stability by synthesizing repetitive DNA sequences at chromosome termini.  These short DNA repeats provide the foundation for specialized chromatin structures, called telomeres, which prevent deleterious chromosome fusion events by differentiating chromosome ends from sites of DNA damage.  It has been shown that telomere length typically decreases with every round of cell division, leading to the so-called ‘molecular clock’ hypothesis, wherein telomere length serves as a signal to control cellular lifespan. This notion is consistent with the finding that active telomere DNA synthesis is normally restricted to rapidly dividing cell types such as stem cells and the majority of human cancers. Our research seeks to elucidate physical mechanisms governing telomere length regulation, and in turn establish a conceptual framework within which to develop novel diagnostic and therapeutic strategies for human disease. [More]

Stone Publications Michael Stone's Email

Prof Bill SullivanCell Cycle, Cytoskeleton and Pathogenesis

Bill Sullivan, Dept. of MCD Biology

The Sullivan lab uses the Drosophila embryo as a model system to investigate the mechanisms that drive furrow invagination during cytokinesis. Through a combination of cellular and molecular genetic approaches, the Sullivan group has showed that furrow formation requires coordinated cell cycle regulated and endocytic-based vesicle recruitment. These studies have also identified a new role for cell cycle checkpoints in coordinating the nuclear cycle with cytokinesis. More recently, the lab has applied these approaches toward understanding the mechanisms by which the widespread intracellular insect pathogen, Wolbachia, influences host nuclear and cytoplasmic cell cycles. [More]

Sullivan's Publications Bill Sullivan's E-Mail

Prof John TamkunRegulation of Chromatin Structure and Gene Expression

John Tamkun, Dept. of MCD Biology

The Tamkun lab investigates regulation of chromatin's high order structure and its role in gene expression. Composed of DNA and proteins, chromatin's ability to fold enables the eukaryotic genome to be packaged into an extremely small space inside the nucleus of the cell. Proper transcription and replication of the genome also depend upon precise regulation of these dynamic structures, with defects in these processes believed to underly many human diseases. [More]

Tamkun Publications John Tamkun's E-Mail

Prof Jin ZhangThe Application of Molecular and Nanomaterial Systems to the Detection and Treatment of Cancer

Jin Zhang , Dept. of Chemistry and Biochemistry

The Zhang research group is interested in the application of molecular and nanomaterial systems in conjunction with optical spectroscopy and related techniques for biomedical detection and treatment, with emphasis on cancer therapies and cancer biomarker detection.  Specific projects include: 1) investigation of mechanisms of photodynamic therapy and catalytic therapy based on porphyrins, phthalocyanines, and related compounds; 2) detection of small molecule, protein, and DNA cancer biomarkers using fluorescence based on quantum dots (QDs) and surface-enhanced Raman scattering (SERS) based on metal nanostrutcures; and 3) photothermal imaging and therapy of cancer using unique metal nanostructures.  This research involves systematic study of the structural, optical, and photophysical as well as photochemical properties of the materials using a combination of microscopy, x-ray, spectroscopy, and electrochemistry techniques. [More]
Zhang Publications Jin Zhang's Email

Prof Martha ZunigaCellular and Molecular Regulation of Antigen Presentation in Health and Disease

Martha Zuñiga, Department of MCD Biology

The Zúñiga lab is interested in the regulation of immune responses in health and disease.  Major Histocompatibility Complex (MHC) molecules (called HLA molecules in humans) present self, tumor, and pathogen-derived antigens to the T cells.  The presentation of MHC molecules in different cellular contexts is of paramount importance in determining immune responsiveness versus tolerance. One major project in the lab focuses on mechanisms of immunological tolerance to cutaneous antigens. We have found that skin-derived regulatory T cells can induce ..... [More]

Martha Zuñiga's Publications Martha Zuñiga's Email
 

PBSci Division | Biomed Home | Biomed Faculty | Research Clusters | Research Facilities | Biocomputing Resources | Training Programs | Give to Biomed Research
Website designed by David States. Click here to send comments or corrections. Last reviewed 8/18/11
© 2008 Regents of the University of California. All rights reserved